Step 1 topics → General Pathology → DNA Repair Defects and Cancer Syndromes

DNA Repair Defects and Cancer Syndromes

USMLE Step 1 trap: Confuses Lynch syndrome's mismatch repair defect with nucleotide excision repair defects (xeroderma pigmentosum). Lynch syndrome is caused by defective mismatch repair (MMR), leading to microsatellite instability and colorectal/endometrial cancer.

DNA repair defect syndromes are tested on USMLE Step 1 both as mechanism questions and as clinical vignettes where a patient's cancer pattern or physical findings point to the syndrome. The most common mix-up is confusing Lynch syndrome with xeroderma pigmentosum — both sound like 'DNA repair cancer syndromes,' but they involve completely different pathways: mismatch repair vs. nucleotide excision repair.

The logic is always the same: identify the damaged DNA substrate, match it to the correct repair pathway, and know what goes wrong clinically when that pathway fails. USMLE Step 1 tests this in two main ways — direct mechanism questions (which pathway repairs UV dimers?) and clinical vignettes where the patient's cancer pattern or physical findings should point you to the syndrome. The exam loves pairing a young patient with sun sensitivity, ataxia, or a striking cancer family history with an underlying repair defect.

The tricky part is that students memorize syndrome names without internalizing pathway specificity. The result is classic mix-ups: Lynch syndrome and xeroderma pigmentosum both sound like 'DNA repair cancer syndromes,' so students conflate them. But the defective pathways are completely different — mismatch repair vs. nucleotide excision repair — and confusing them on Step 1 loses you an easy point. You also need to know that not every repair defect syndrome is about cancer risk alone; ataxia-telangiectasia and Fanconi anemia have prominent neurologic and hematologic features that precede or coexist with malignancy.

The best way to lock this in is to organize by pathway first, then attach syndromes. Mismatch repair → Lynch. Nucleotide excision repair → xeroderma pigmentosum. Double-strand break sensing/repair → ataxia-telangiectasia, BRCA1/2, Fanconi anemia, Bloom syndrome. Once that backbone is solid, the clinical features follow logically from which tissues are most exposed to the relevant mutagen or most dependent on that pathway.

From real student decks
32%have cards covering this topic
11%have mature cards

A gap in most decks — fewer than half of students in our cohort have cards covering this topic.

Common misconceptions

Common mistake
Wrong: Lynch syndrome results from a defect in nucleotide excision repair.
Right: Lynch syndrome is caused by defective mismatch repair (MMR), leading to microsatellite instability and colorectal/endometrial cancer.
Lynch syndrome is caused by mutations in MMR genes (MLH1, MSH2, MSH6, PMS2), which fix single-base mismatches introduced during DNA replication. Nucleotide excision repair is a completely different pathway that handles bulky lesions like UV-induced pyrimidine dimers — that's xeroderma pigmentosum territory. The clue that Lynch is MMR is microsatellite instability: repetitive sequences accumulate errors when MMR fails, and this shows up on tumor testing as MSI-high.
Common mistake
Wrong: Xeroderma pigmentosum involves defective base excision repair of UV-induced pyrimidine dimers.
Right: Xeroderma pigmentosum involves defective nucleotide excision repair (NER), which is the pathway responsible for removing bulky UV-induced pyrimidine dimers.
UV light creates pyrimidine dimers, which are bulky helix-distorting lesions — and bulky lesions are the signature substrate of nucleotide excision repair (NER), not base excision repair (BER). BER handles small, non-helix-distorting base modifications like oxidized or alkylated bases. XP patients have defective NER, so pyrimidine dimers accumulate with every sun exposure, driving mutations in skin cells and leading to early-onset skin cancers. The 'bulky lesion → NER' association is the key rule to engrave.
Common mistake
Gap: Missing the ATM kinase / double-strand break sensing mechanism underlying ataxia-telangiectasia
Ataxia-telangiectasia results from ATM kinase deficiency, impairing double-strand break sensing and p53 activation, causing cerebellar ataxia, telangiectasias, and lymphoid malignancy risk.
ATM (ataxia-telangiectasia mutated) is a kinase that acts as the cell's sensor for double-strand DNA breaks — it's one of the first responders that phosphorylates and activates p53, triggering cell cycle arrest and apoptosis. Without functional ATM, cells with double-strand breaks keep dividing instead of being culled, accumulating chromosomal rearrangements. The clinical triad — cerebellar ataxia, oculocutaneous telangiectasias, and lymphoid malignancies — reflects both the role of ATM in neuronal development and the lymphocyte dependence on proper DSB repair during V(D)J recombination.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a DNA repair pathway (e.g., mismatch repair, nucleotide excision repair, double-strand break repair), identify which syndrome results from a defect in that pathway and explain the molecular mechanism behind it.
  2. Given a clinical vignette describing a patient's cancer type, physical findings, or family history, identify the underlying DNA repair defect syndrome and name the specific pathway that is broken.

Can you avoid these mistakes?

A 28-year-old woman is found to have endometrial cancer. Her mother had colon cancer at 42, and her uncle had urinary tract cancer. Tumor testing shows microsatellite instability. What is the underlying repair pathway defect, and which genes are most likely involved?
You're given two patients: one with severe sunburn-induced skin cancers starting in childhood, another with colon cancer and a family history of Lynch syndrome. Both have DNA repair defects. What distinguishes the specific repair pathway broken in each patient, and what is the molecular substrate each pathway normally handles?
A 10-year-old boy presents with progressive cerebellar ataxia and spider-like dilated vessels on his sclera. His lymphocyte count is low and he has had two episodes of lymphoma. What kinase is deficient, what type of DNA damage does it normally sense, and why does p53 fail to do its job in this condition?
A genetics fellow is counseling four patients: one whose tumor shows MSI-high on molecular testing, one with childhood-onset skin cancers after minimal sun exposure and a known NER defect, one with cerebellar ataxia and oculocutaneous telangiectasias, and one with hereditary breast cancer on BRCA1 testing. For each patient, identify which DNA repair pathway is broken, which substrate that pathway normally handles, and name the syndrome if applicable.

Related topics

Tumor Suppressors (Knudson Two-Hit) Reversible vs Irreversible Cell Injury Types of Necrosis Apoptosis (Intrinsic and Extrinsic Pathways) Cell Adaptations (Atrophy, Hypertrophy, Hyperplasia, Metaplasia, Dysplasia)

See how your Anki deck covers this topic.

Upload your deck for a free audit →